Tue, Sep 2, 2014, 12:23 AM EDT - U.S. Markets open in 9 hrs 7 mins


% | $
Quotes you view appear here for quick access.

Celgene Corp. (CELG) Message Board

  • drmiller355 drmiller355 Jan 11, 2013 12:01 PM Flag

    3 More New Blockbusters Drugs Coming 2013- 12 Billion Revenue. Read

    Seeking Alpha Market Currents
    Celgene Corp. (CELG +3.1%) updates guidance, saying it expects FY12 income to come in at the higher end of previous estimates and in-line results for 2013. Net product sales are expected to double between 2013 and 2017, reaching over $12B, with numerous milestones expected in 2013 for three "potential blockbuster" drugs. One of the drugs is its existing cancer drug Abraxane, which it hopes to have approved as a treatment for pancreatic cancer - which is among the hardest to treat - sometime this year.

95.02+0.32(+0.34%)Aug 29 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Exelixis, Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Criteo SA
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT